The Antidiabetic Effect of MSCs Is Not Impaired by Insulin Prophylaxis and Is Not Improved by a Second Dose of Cells

Type 1 diabetes mellitus (T1D) is due to autoimmune destruction of pancreatic beta-cells. Previously, we have shown that intravenously administered bone marrow-derived multipotent mesenchymal stromal cells (MSCs) allows pancreatic islet recovery, improves insulin secretion and reverts hyperglycemia...

Descripción completa

Detalles Bibliográficos
Autores principales: Ezquer, Fernando, Ezquer, Marcelo, Simon, Valeska, Conget, Paulette
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3029393/
https://www.ncbi.nlm.nih.gov/pubmed/21304603
http://dx.doi.org/10.1371/journal.pone.0016566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3029393/
https://www.ncbi.nlm.nih.gov/pubmed/21304603
http://dx.doi.org/10.1371/journal.pone.0016566

Ejemplares similares